Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

Combines Achilles’ best-in-class AI-driven, tumor-targeting technology with Arcturus’ world-leading self-amplifying mRNA platform

Combined technologies have the potential to generate potent and durable T cell responses in pre-clinical IND-enabling studies        

Read more at globenewswire.com